For the first time, we can show that a targeted screening programme is not only going to save lives but is cost effective. We can also see a path to a universal screening programme.
This wouldn’t have been possible without the incredible support of our community over the last six months. Thanks to everyone who signed the petition, wrote to their MP, or shared our message with their community.
See the link below to read our full report.
We are making three exciting recommendations which are:
Right now, we need to optimise screening using a PSA test, focusing on high-risk groups – Black men, those with a family history, and those with a BRCA1 or BRCA2 mutation. This approach, prioritising those at highest risk of prostate cancer, has been shown in our report to provide economic benefits, while requiring the lowest level of health system change.
Alongside more targeted PSA testing, we need to focus on getting new diagnostic technologies into trial (e.g. reflex tests), to gather real-world evidence and understand the benefit in diverse populations. Once the value of this has been demonstrated, we should expand the screening programme to cover the general population using a test with greater accuracy, as this will realise the greatest economic benefits.
To further improve patient outcomes and the economic benefits of earlier detection, we need to integrate AI technology into the NHS. We need to leverage its potential to improve the accuracy and reliability of screening, avoiding the need for unnecessary biopsies, while also boosting operational efficiencies. By adopting AI-driven technologies in imaging, we can streamline processes, reduce diagnostic errors and ensure resources are allocated more effectively.
We have challenges ahead, but with your help, we can overcome them and change the future of prostate cancer screening for men across the country.
Read our report in full here